drugset / Trial / NCT01640730

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

NCT01640730 ↗

Phase 2 Terminated 1 enrolled KangLaiTe USA
NaSingle-groupOpen-labelTreatment

Summary

This study is for patients with advanced non small cell lung cancer that has progressed despite standard of care. The purpose of the study is to see if Kanglaite injection has any effect on survival.

Timeline

Start
2012-05
Primary completion
2012-10
Completion
2012-10

Outcome

Outcome not reported

Stopped (Enrollment): “poor enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Kanglaite Injection Unknown 30 g Intravenous